Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055184/0552 | |
| Pages: | 7 |
| | Recorded: | 02/08/2021 | | |
| Attorney Dkt #: | CHROM-130-US-CON |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
12/13/2022
|
Application #:
|
17114864
|
Filing Dt:
|
12/08/2020
|
|
Publication #:
|
|
Pub Dt:
|
07/29/2021
| | | | |
|
Title:
|
USE OF NICOTINAMIDE RIBOSIDE, NICOTINIC ACID RIBOSIDE, AND NICOTINAMIDE MONONUCLEOTIDE, REDUCED NICOTINYL COMPOUNDS, AND NICOTINOYL COMPOUND DERIVATIVES IN INFANT FORMULA FOR HEALTHY DEVELOPMENT
|
|
|
Assignee
|
|
|
|
|
| 10005 MUIRLANDS BLVD. |
| IRVINE, CALIFORNIA 92618 |
|
|
Correspondence name and address
|
| |
AMIN TALATI WASSERMAN LLP
|
| |
100 S. WACKER DRIVE
|
| |
SUITE 2000
|
| |
CHICAGO, IL 60606
|
Search Results as of:
06/06/2024 06:06 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
